These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9467791)

  • 21. Pharmacologic management of relapse prevention in addictive disorders.
    Sofuoglu M; Kosten TR
    Psychiatr Clin North Am; 2004 Dec; 27(4):627-48. PubMed ID: 15550284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Classification and short-term course of DSM-IV cannabis, hallucinogen, cocaine, and opioid disorders in treated adolescents.
    Chung T; Martin CS
    J Consult Clin Psychol; 2005 Dec; 73(6):995-1004. PubMed ID: 16392973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic vaccines for substance dependence.
    Haney M; Kosten TR
    Expert Rev Vaccines; 2004 Feb; 3(1):11-8. PubMed ID: 14761239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Supplementary prescribing in the substance misuse field.
    Harniman B
    Nurs Times; 2006 Feb 21-27; 102(8):30-2. PubMed ID: 16519032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cocaine Rapid Efficacy Screening Trials (CREST): lessons learned.
    Kampman KM; Leiderman D; Holmes T; LoCastro J; Bloch DA; Reid MS; Shoptaw S; Montgomery MA; Winhusen TM; Somoza EC; Ciraulo DA; Elkashef A; Vocci F
    Addiction; 2005 Mar; 100 Suppl 1():102-10. PubMed ID: 15730354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ['Pharmacologic interventions in drug addiction': an advisory report from the Health Council of the Netherlands].
    Goppel MA; van den Brink W; van Ree JM
    Ned Tijdschr Geneeskd; 2003 Aug; 147(34):1637-40. PubMed ID: 12966629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of quantitative urinalysis in monitoring cocaine use.
    Preston KL; Silverman K; Schuster CR; Cone EJ
    NIDA Res Monogr; 1997; 175():253-64. PubMed ID: 9467803
    [No Abstract]   [Full Text] [Related]  

  • 28. Chronic disulfiram treatment effects on intranasal cocaine administration: initial results.
    McCance-Katz EF; Kosten TR; Jatlow P
    Biol Psychiatry; 1998 Apr; 43(7):540-3. PubMed ID: 9547934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependence.
    Elkashef A; Holmes TH; Bloch DA; Shoptaw S; Kampman K; Reid MS; Somoza E; Ciraulo D; Rotrosen J; Leiderman D; Montgomery A; Vocci F
    Addiction; 2005 Mar; 100 Suppl 1():91-101. PubMed ID: 15730353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances against substance abuse.
    Heading CE
    IDrugs; 2003 Jul; 6(7):681-7. PubMed ID: 12861473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacotherapeutic environments for substance use disorders.
    Gardner TJ; Kosten TR
    Am J Drug Alcohol Abuse; 2007; 33(5):627-9. PubMed ID: 17891655
    [No Abstract]   [Full Text] [Related]  

  • 32. Buprenorphine: its role in preventing HIV transmission and improving the care of HIV-infected patients with opioid dependence.
    Sullivan LE; Fiellin DA
    Clin Infect Dis; 2005 Sep; 41(6):891-6. PubMed ID: 16107991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The beta-lactam antibiotic ceftriaxone inhibits physical dependence and abstinence-induced withdrawal from cocaine, amphetamine, methamphetamine, and clorazepate in planarians.
    Rawls SM; Cavallo F; Capasso A; Ding Z; Raffa RB
    Eur J Pharmacol; 2008 Apr; 584(2-3):278-84. PubMed ID: 18342307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of gamma-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction.
    Brodie JD; Figueroa E; Laska EM; Dewey SL
    Synapse; 2005 Feb; 55(2):122-5. PubMed ID: 15543630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of narcotics in addict therapy.
    Halliday R
    Can Nurse; 1967 Mar; 63(3):39-41. PubMed ID: 6017177
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacological manipulations of the pedunculopontine tegmental nucleus in the rat reduce self-administration of both nicotine and cocaine.
    Corrigall WA; Coen KM; Zhang J; Adamson L
    Psychopharmacology (Berl); 2002 Mar; 160(2):198-205. PubMed ID: 11875638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical freedom and drug dependence. No rationale for prescribing cocaine to addicts.
    Johns A
    BMJ; 1993 Dec; 307(6918):1565. PubMed ID: 8123150
    [No Abstract]   [Full Text] [Related]  

  • 38. Development of vaccines to help treat drug dependence.
    Bunce CJ; Loudon PT; Akers C; Dobson J; Wood DM
    Curr Opin Mol Ther; 2003 Feb; 5(1):58-63. PubMed ID: 12669472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substance use of disorders in HIV-infected patients: impact and new treatment strategies.
    Fiellin DA
    Top HIV Med; 2004; 12(3):77-82. PubMed ID: 15310938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of 2beta-propanoyl-3beta-(4-tolyl)-tropane (PTT) on the self-administration of cocaine, heroin, and cocaine/heroin combinations in rats.
    Sizemore GM; Davies HM; Martin TJ; Smith JE
    Drug Alcohol Depend; 2004 Mar; 73(3):259-65. PubMed ID: 15036548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.